FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116509006: Alosetron (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177388010 Alosetron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679170011 Alosetron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alosetron Is a Product containing 5-hydroxytryptamine-3-receptor antagonist (product) false Inferred relationship Some
Alosetron Is a 5-HT3 receptor antagonist true Inferred relationship Some
Alosetron Is a agent contre une maladie inflammatoire de l'intestin false Inferred relationship Some
Alosetron Is a Carboline (substance) true Inferred relationship Some
Alosetron This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. 5-HT3 receptor antagonist true Inferred relationship Some
Alosetron Is a Gastrointestinal agent (substance) true Inferred relationship Some
Alosetron Is a allergène médicamenteux false Inferred relationship Some
Alosetron Is a Imidazole true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Alosetron hydrochloride (substance) Is a False Alosetron Inferred relationship Some
Product containing alosetron (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alosetron Inferred relationship Some 1
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alosetron Inferred relationship Some
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alosetron Inferred relationship Some 1
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Alosetron Inferred relationship Some 1
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Alosetron Inferred relationship Some 1
Alosetron-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alosetron Inferred relationship Some 1
Alosetron hydrochloride (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Alosetron Inferred relationship Some
Alosetron only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alosetron Inferred relationship Some 1
Alosetron only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Alosetron Inferred relationship Some 1
Product containing precisely alosetron (as alosetron hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alosetron Inferred relationship Some 1
Alosetron (as alosetron hydrochloride) 500 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Alosetron Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

Back to Start